Latest Breaking News On - January neovacs - Page 1 : comparemela.com
PARIS, France, May 22th, 2023, 08:30 am CET – Pharnext SCA , an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases with high. | May 22, 2023
PARIS, France, May 22th, 2023, 08:30 am CET - Pharnext SCA (FR001400GUN7 - ALPHA) (the "Company"), an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative